Almeida, Felipe Campos de 
; Berzoti-Coelho, Maria Gabriela ; Toro, Diana Mota; Cacemiro, Maira da Costa ; Bassan, Vitor Leonardo ; Barretto, Gabriel Dessotti ; Garibaldi, Pedro Manoel Marques; Palma, Leonardo Carvalho ; Pontes, Lorena Lobo de Figueiredo ; Sorgi, Carlos Arterio ; Faccioli, Lucia Helena ; Gardinassi, Luiz Gustavo Araujo ; Castro, Fabíola Attié de
Source: Frontiers in Immunology. Unidades: FCFRP, FMRP, FFCLRP, IQ
Subjects: BIOMARCADORES, NEOPLASIAS, LEUCEMIA MIELOIDE, FARMACOTERAPIA, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Felipe Campos de et al. Bioactive lipids as chronic myeloid leukemia’s potential biomarkers for disease progression and response to tyrosine kinase inhibitors. Frontiers in Immunology, v. 13, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.840173. Acesso em: 26 jan. 2026.APA
Almeida, F. C. de, Berzoti-Coelho, M. G., Toro, D. M., Cacemiro, M. da C., Bassan, V. L., Barretto, G. D., et al. (2022). Bioactive lipids as chronic myeloid leukemia’s potential biomarkers for disease progression and response to tyrosine kinase inhibitors. Frontiers in Immunology, 13, 1-8. doi:10.3389/fimmu.2022.840173NLM
Almeida FC de, Berzoti-Coelho MG, Toro DM, Cacemiro M da C, Bassan VL, Barretto GD, Garibaldi PMM, Palma LC, Pontes LL de F, Sorgi CA, Faccioli LH, Gardinassi LGA, Castro FA de. Bioactive lipids as chronic myeloid leukemia’s potential biomarkers for disease progression and response to tyrosine kinase inhibitors [Internet]. Frontiers in Immunology. 2022 ; 13 1-8.[citado 2026 jan. 26 ] Available from: https://doi.org/10.3389/fimmu.2022.840173Vancouver
Almeida FC de, Berzoti-Coelho MG, Toro DM, Cacemiro M da C, Bassan VL, Barretto GD, Garibaldi PMM, Palma LC, Pontes LL de F, Sorgi CA, Faccioli LH, Gardinassi LGA, Castro FA de. Bioactive lipids as chronic myeloid leukemia’s potential biomarkers for disease progression and response to tyrosine kinase inhibitors [Internet]. Frontiers in Immunology. 2022 ; 13 1-8.[citado 2026 jan. 26 ] Available from: https://doi.org/10.3389/fimmu.2022.840173
